ATE184055T1 - Verfahren zum sensitiven nachweis von reverser transcriptase - Google Patents

Verfahren zum sensitiven nachweis von reverser transcriptase

Info

Publication number
ATE184055T1
ATE184055T1 AT96903748T AT96903748T ATE184055T1 AT E184055 T1 ATE184055 T1 AT E184055T1 AT 96903748 T AT96903748 T AT 96903748T AT 96903748 T AT96903748 T AT 96903748T AT E184055 T1 ATE184055 T1 AT E184055T1
Authority
AT
Austria
Prior art keywords
dna
biological sample
synthesized
sensitive detection
retrovirus
Prior art date
Application number
AT96903748T
Other languages
English (en)
Inventor
Walid Heneine
Thomas M Folks
William Marshall Switzer
Shinji Yamamoto
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE184055T1 publication Critical patent/ATE184055T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT96903748T 1995-01-27 1996-01-26 Verfahren zum sensitiven nachweis von reverser transcriptase ATE184055T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37985195A 1995-01-27 1995-01-27

Publications (1)

Publication Number Publication Date
ATE184055T1 true ATE184055T1 (de) 1999-09-15

Family

ID=23498979

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96903748T ATE184055T1 (de) 1995-01-27 1996-01-26 Verfahren zum sensitiven nachweis von reverser transcriptase

Country Status (7)

Country Link
US (2) US5849494A (de)
EP (1) EP0805873B1 (de)
JP (2) JP4256931B2 (de)
AT (1) ATE184055T1 (de)
AU (1) AU710468B2 (de)
DE (1) DE69604051T2 (de)
WO (1) WO1996023076A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69604051T2 (de) * 1995-01-27 1999-12-16 The Government Of The United States Of America, As Represented By The Secretary Verfahren zum sensitiven nachweis von reverser transcriptase
US5897620A (en) * 1997-07-08 1999-04-27 Priceline.Com Inc. Method and apparatus for the sale of airline-specified flight tickets
IL134137A0 (en) * 1997-07-22 2001-04-30 Novimmune Sa Methods for diagnosis and theraphy of autoimmune diseases, such as insulin dependent diabetes mellitus, involving retroviral superantigens
EP0893691A1 (de) * 1997-07-23 1999-01-27 Mach, Bernard François, Prof. Verfahren für die Diagnose undTherapie von Autoimmunerkrankungen, die mit retroviralen Superantigenen zusammenhängen, wie z.B. insulinabhängigen diabetus mellitus
US6787126B1 (en) 1998-06-19 2004-09-07 The United States Of America As Represented By The Department Of Health And Human Services Method and kit for detecting resistance to antiviral drugs
US20030148307A1 (en) 1998-06-19 2003-08-07 Department Of Health & Human Services, C/O Centers Of Disease Control And Prevention Method and kit for detecting resistance to antiviral drugs
CA2331260C (en) * 1998-06-19 2008-03-18 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method and kit for detecting resistance to antiviral drugs
US6271022B1 (en) 1999-03-12 2001-08-07 Biolog, Inc. Device for incubating and monitoring multiwell assays
US6582901B2 (en) * 2000-04-26 2003-06-24 Bruce K. Patterson Cell specific anti-viral drug susceptibility test using tagged permissive target cells
WO2001098541A2 (en) * 2000-06-21 2001-12-27 Harris Robert B Measuring viral reverse transcriptase activity
US6582920B2 (en) * 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
EP2309269B1 (de) * 2004-09-08 2016-10-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Zusammensetzungen und verfahren zur detektion von hiv-1/hiv-2 infektion
BR112019027993A2 (pt) 2017-07-04 2020-07-07 Cavidi Ab métodos para avaliar a susceptibilidade de um vírus ao tratamento com um fármaco inibidor de uma enzima do vírus do tipo selvagem, para avaliar se um paciente tratado para uma infecção viral tem necessidade de alterar a terapia farmacológica com um fármaco inibidor da enzima viral e para determinar a carga de um vírus em uma amostra do paciente e a dita resistência do vírus ao tratamento com um fármaco inibidor de uma enzima do vírus do tipo selvagem, e, sistema

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE289603C (de) *
US4707439A (en) * 1984-10-26 1987-11-17 The United States Of America As Represented By The Department Of Health And Human Services Screening test for reverse-transcriptase containing virus such as non-A, non-B hepatitis, NANBH
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5066782A (en) * 1986-01-22 1991-11-19 Institut Pasteur Retrovirus capable of causing AIDS, means and method for detecting it in vitro
US5407800A (en) * 1986-08-22 1995-04-18 Hoffmann-La Roche Inc. Reverse transcription with Thermus thermophilus polymerase
HU209835B (en) * 1988-12-07 1994-11-28 Univ Osaka Res Found Method for producing of retrovirus protease, reverse transcriptase and integrase
US5320958A (en) * 1989-02-24 1994-06-14 University Of Medicine And Dentistry Of New Jersey Isolated bacterial reverse transcriptase
US5434070A (en) * 1989-02-24 1995-07-18 The University Of Medicine And Dentistry Of New Jersey Reverse transcriptases from Escherichia coli and Myxococcus xanthus
DE69021425T2 (de) * 1989-04-14 1996-04-25 Asahi Chemical Ind Verfahren zur Messung von Reverse-Transcriptase mit nichtradioaktiven Substanzen.
US5354866A (en) * 1989-05-23 1994-10-11 Abbott Laboratories Retroviral protease inhibiting compounds
JP3011987B2 (ja) * 1990-10-11 2000-02-21 旭化成工業株式会社 固相化プライマーを用いる逆転写酵素の測定法
US5124327A (en) * 1991-09-06 1992-06-23 Merck & Co., Inc. HIV reverse transcriptase
US5527819A (en) * 1991-09-06 1996-06-18 Merck & Co., Inc. Inhibitors of HIV reverse transcriptase
US6316182B1 (en) * 1992-01-15 2001-11-13 Nen Life Science Products, Inc. Detection of reverse transcriptase by DNA hybridization assay
US5591770A (en) * 1992-03-31 1997-01-07 The United States Of America As Represented By The Department Of Health And Human Services Calanolide and related antiretroviral compounds, compositions, and uses thereof
EP0623176B1 (de) * 1992-05-11 2000-01-19 Jörg SCHÜPBACH Verfahren zum nachweis reverser transcriptase
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
US5360714A (en) * 1992-08-28 1994-11-01 Fox Chase Cancer Center Hepadnavirus polymerase gene product having RNA-dependent DNA priming and reverse transcriptase activities and methods of measuring the activities thereof
US6268123B1 (en) * 1993-06-01 2001-07-31 Retro-Tech Gmbh Direct and biochemically functional detection process of retrovirus in biological samples
ATE374253T1 (de) * 1994-10-20 2007-10-15 Pasteur Institut Nukleotiden-sequenzen aus retroviren-antigenen hiv-i gruppe (oder untergruppe) o
DE69604051T2 (de) * 1995-01-27 1999-12-16 The Government Of The United States Of America, As Represented By The Secretary Verfahren zum sensitiven nachweis von reverser transcriptase
DE69602122T2 (de) * 1995-03-07 1999-08-19 Matsushita Electric Industrial Co. Flache Zelle

Also Published As

Publication number Publication date
EP0805873A1 (de) 1997-11-12
EP0805873B1 (de) 1999-09-01
JP4256931B2 (ja) 2009-04-22
DE69604051T2 (de) 1999-12-16
US6136534A (en) 2000-10-24
AU4773196A (en) 1996-08-14
US5849494A (en) 1998-12-15
AU710468B2 (en) 1999-09-23
JPH11505101A (ja) 1999-05-18
WO1996023076A1 (en) 1996-08-01
JP2007006897A (ja) 2007-01-18
DE69604051D1 (de) 1999-10-07

Similar Documents

Publication Publication Date Title
ATE368125T1 (de) Verfahren zur erkennung von einzel-nukleotid- polymorphismen
ATE92538T1 (de) Verstaerkung und nachweis von nukleinsaeuresequenzen.
DE68901285D1 (de) Verfahren zum nachweis von nukleotid-sequenzen.
DE59509937D1 (de) Verfahren zur Quantifizierung von genomischer DNA
DE3752178D1 (de) Verfahren zum Nachweis HTLVI- und HTLVII-Viren mittels Hybridizierung
ATE215993T1 (de) Nachweis von nukleinsäuren mit breitem dynamikbereich unter verwendung von aggregat- primer-reihen
ATE191934T1 (de) Verfahren zur isothermer amplifikation von nukleinsäure molekülen
ATE506454T1 (de) Verfahren zum nachweis von cytosin-methylierung mit hoher sensitivität
ATE184055T1 (de) Verfahren zum sensitiven nachweis von reverser transcriptase
DK0656955T3 (da) Elimination af falske negative testresultater i nukleinsyredetektering
DE69618460D1 (de) Verfahren zum nachweis von nukleinsäuresequenzen unter verwendung von kompetitiven amplifikation
ATE220726T1 (de) Oligonukleotid-primer für amplifizierung von hcv- nukleinsäure
DE59606675D1 (de) Verfahren zum nachweis von telomerase-aktivität
ATE421999T1 (de) Nachweis von hiv-1 durch amplifizierung von nukleinsäuren
DE69916650T2 (de) Verfahren und system zur erkennung von oligonukleotiden in einer probe
DE69717840D1 (de) Nachweis und identifizierung von nicht-polio enteroviren
WO1998026097A3 (en) NUCLEIC ACID PRIMERS AND PROBES FOR DETECTING $i(LEGIONELLA PNEUMOPHILA)
DE60043618D1 (de) Verfahren zum nachweis einer reaktion zur molekularen erkennung
CA2211165A1 (en) Methods for sensitive detection of reverse transcriptase
ATE197481T1 (de) Verfahren und reagenzien zur typisierung von hla- genen der klasse i
ATE290605T1 (de) Verfahren und reagentiensatz zur erkennung von antiviralen wirkstoff resistenzen
DE60216827D1 (de) Verfahren und Vorrichtung zur Bestimmung von amplifizierten Genprodukten zum Nachweis eines Gens

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties